Skip to main content
Andor Glaudemans
prof. dr.

I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.

Somatostatin receptor scintigraphy in patients with rheumatoid arthritis and secondary Sjogren’s syndrome treated with Infliximab: a pilot study
Published in: EJNMMI Research
Access to document 10.1186/s13550-016-0202-y document
Background: Human T lymphocytes infiltrating tissues in autoimmune diseases are known to express somatostatin receptors amongst other activation markers. In this study, we evaluated whether somatostatin receptor scintigraphy (SRS) using a radiolabelled somatostatin analogue (Tc-99m-EDDA/tricine-HYNIC-tyr(3)-octreotide (Tc-99m-EDDA/HYNIC-TOC)) is able to detect the presence of immune-mediated processes in patients with rheumatoid arthritis and secondary Sjogren’s syndrome. We also aimed to evaluate whether positivity to SRS was predictive of therapeutic response and if SRS could be used for monitoring the efficacy of immunomodulatory treatment. Methods: Eighteen patients with rheumatoid arthritis and...
L. K. Anzola-Fuentes, M. Chianelli, F. Galli, A. W. J. M. Glaudemans, L. Martin Martin, V. Todino, A. Migliore, A. Signore
In vivo imaging of microorganisms
Published in: Clinical and Translational Imaging
Access to document 10.1007/s40336-016-0176-9
Alberto Signore, Iolanda Santino, Andor W.J.M. Glaudemans
A Phase 1 study of RAD1901, an oral selective estrogen receptor degrader, in ER positive, HER2 negative, advanced breast cancer patients.
Published in: Journal of Clinical Oncology
Access to document 10.1200/JCO.2016.34.15_suppl.TPS627
Elisabeth G. E. de Vries, Clasina Marieke Venema, Andor W. J. M. Glaudemans, Lorraine Fitzpatrick, Dinesh Purandare, Gary Hattersley, Fiona Garner
Androgen receptor and estrogen receptor imaging in patients with metastatic breast cancer.
Published in: Journal of Clinical Oncology
Access to document 10.1200/JCO.2016.34.15_suppl.11553
Clasina Marieke Venema, Lemonitsa H. Mammatas, Michel van Kruchten, Giulia Apollonio, Carolina Pia Schröder, Andor W. J. M. Glaudemans, Otto S. Hoekstra, Henk M. W. Verheul, Bert van der Vegt, Erik F. J. De Vries, Elisabeth G. E. de Vries, Catharina Wilhelmina Menke, Geke Hospers
Imaging latent tuberculosis infection with radiolabeled nitroimidazoles
Published in: Clinical and Translational Imaging
Access to document 10.1007/s40336-016-0166-y document
Alfred O Ankrah, Andor W J M Glaudemans, Mike M Sathekge, Hans C Klein